Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

Effecty vs MadeMed

Effecty
Graded #29

Higher grade

vs+3.299999999999997
MadeMed
Graded #30

Lower grade

The verdict

Effecty takes it — 83.7/100 to 80.4/100.

Effecty grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Mid-market pricing offset by brand-name access and LegitScript verification, all 50 states.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueEffecty +6
80
74
Dose & formulationMadeMed +6
84
90
Clinical oversightEffecty +1
85
84
Labs & monitoringEffecty +22
84
62
FulfillmentMadeMed +3
87
90
Contract termsMadeMed +2
86
88
Effecty · left barMadeMed · right bar

The numbers

MetricEffectyMadeMed
WeighScore83.7/10080.4/100
GradeBB−
Scorecard rank#29#30
Semaglutide$160/mo$239/mo quarterly (from $199/mo on 6 months)
Tirzepatide$240/mo$399/mo quarterly (from $369/mo on 6 months)
CoverageAll 50 states40 states
Brand-name accessYesCompounded only
Oral / sublingualInjection onlyYes
Effecty

Graded #29 · B

Strengths

  • Brand-name access
  • LegitScript-verified, all 50 states
  • Both molecules

Where it loses points

  • Higher pricing ($160/$240)
  • Injection-only
  • Not a value leader
MadeMed

Graded #30 · B−

Strengths

  • One flat price at every dose, published dose by dose — semaglutide 0.25–2.4mg, tirzepatide 2.5–15mg
  • LegitScript verified, with board-certified physician review and US compounding pharmacies
  • Full refund minus a $39 visit fee if you are not prescribed, stated before checkout
  • Oral semaglutide and oral tirzepatide alongside the injections; free overnight shipping with supplies

Where it loses points

  • The most expensive tirzepatide here at $399/mo quarterly
  • 40 states rather than nationwide
  • No published recurring lab programme
  • Ships one vial every two months, a less flexible cadence than a monthly refill

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard